(Q38087391)

28 August 2017

title

The application of aptamers in cancer research: an up-to-date review (English)

1 reference

28 August 2017

Meidi Hu

1

1 reference

28 August 2017

Kunhe Zhang

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

9

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

369-376

1 reference

Hallmarks of Cancer: The Next Generation

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Cancer prevention and early detection efforts continue to make strides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

The functional cancer map: a systems-level synopsis of genetic deregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Predictive markers of colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Assays for cytokines using aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Applications of aptamers in cancer cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Methods for measuring aptamer-protein equilibria: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamers against cell surface receptors: selection, modification and application

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

21 January 2018

Complex target SELEX.

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Development of DNA aptamers using Cell-SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamers: potential applications to pancreatic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamer applications for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamers as innovative diagnostic and therapeutic agents in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Analytical applications of aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Fluorescence protection assay: a novel homogeneous assay platform toward development of aptamer sensors for protein detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptasensors--the future of biosensing?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamers evolved from live cells as effective molecular probes for cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

DNA aptamers as molecular probes for colorectal cancer study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

High affinity ligands from in vitro selection: complex targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Selection of aptamers for molecular recognition and characterization of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Molecular recognition of acute myeloid leukemia using aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Identification of liver cancer-specific aptamers using whole live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Molecular recognition of small-cell lung cancer cells using aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Nanotechnology and aptamers: applications in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Stable feature selection for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Cell-specific aptamer probes for membrane protein elucidation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Improving the stability of aptamers by chemical modification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Molecular aptamers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Disposable nucleic acid biosensors based on gold nanoparticle probes and lateral flow strip.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Nanoparticle-aptamer conjugates for cancer cell targeting and detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Enrichment of cancer cells using aptamers immobilized on a microfluidic channel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamers as therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Tumor-targeted drug delivery with aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Aptamer mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Antiangiogenic therapy using nanotechnological-based delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Chimeric aptamers in cancer cell-targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Molecular imaging with nucleic acid aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

DNA aptamer functionalized nanomaterials for intracellular analysis, cancer cell imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Detection of oncoprotein platelet-derived growth factor using a fluorescent signaling complex of an aptamer and TOTO.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Tenascin-C aptamers are generated using tumor cells and purified protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Targeting Axl with an high-affinity inhibitory aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

Inhibition of cell proliferation by an anti-EGFR aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.201

21 January 2018

Identifiers

DOI

10.2217/FON.12.201

1 reference

28 August 2017

1 reference